IDEX Biometrics ASA Statistics
Total Valuation
IDXAF has a market cap or net worth of 16.97 million. The enterprise value is 17.37 million.
| Market Cap | 16.97M |
| Enterprise Value | 17.37M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +64.15% |
| Shares Change (QoQ) | +68.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.74B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.18 |
| PB Ratio | 3.60 |
| P/TBV Ratio | 4.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.20 |
| EV / Sales | 18.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.50.
| Current Ratio | 2.67 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.08 |
Financial Efficiency
Return on equity (ROE) is -180.08% and return on invested capital (ROIC) is -107.94%.
| Return on Equity (ROE) | -180.08% |
| Return on Assets (ROA) | -77.65% |
| Return on Invested Capital (ROIC) | -107.94% |
| Return on Capital Employed (ROCE) | -320.41% |
| Revenue Per Employee | 28,033 |
| Profits Per Employee | -481,633 |
| Employee Count | 30 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14,900.00% in the last 52 weeks. The beta is 2.06, so IDXAF's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +14,900.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDXAF had revenue of 841,000 and -14.45 million in losses. Loss per share was -0.03.
| Revenue | 841,000 |
| Gross Profit | -843,000 |
| Operating Income | -21.90M |
| Pretax Income | -14.57M |
| Net Income | -14.45M |
| EBITDA | -20.88M |
| EBIT | -21.90M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 2.01 million in cash and 2.38 million in debt, giving a net cash position of -368,000.
| Cash & Cash Equivalents | 2.01M |
| Total Debt | 2.38M |
| Net Cash | -368,000 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.71M |
| Book Value Per Share | 0.01 |
| Working Capital | 5.79M |
Cash Flow
| Operating Cash Flow | -17.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -100.24% |
| Operating Margin | -2,604.40% |
| Pretax Margin | -1,732.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDXAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -64.15% |
| Shareholder Yield | -64.15% |
| Earnings Yield | -85.14% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
IDXAF has an Altman Z-Score of -49.37. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -49.37 |
| Piotroski F-Score | n/a |